Guide: Exporting parenterals to the EU post BREXIT

The UK’s withdrawal from the EU has had an impact on customs procedures, tax and trade, both with the EU and non-EU countries and this also applies to exportation of drug product to the EU from the UK. But what are the implications of this significant manoeuvre for the biopharma and CMO/CDMO sectors? In this guide we review the consequences and impact and the implications for sponsors as they look to get their therapy to market.